Coastal view of the cliffs of Miraflores in Lima, the city where the subsidiary of the Ferrer pharmaceutical group is located in Peru.

Global presence

Ferrer Peru

Two people from the Ferrer team work together in front of a laptop, smiling in an office environment and wearing corporate T-shirts.

Ferrer Peru works to contribute to more equitable access to quality therapies, in an environment where the challenges of access and healthcare coordination are still relevant. Our approach combines scientific rigour, closeness and active collaboration with the different actors in the health system.

 

We work closely with healthcare professionals, managers and communities to drive solutions that deliver real clinical value and improve patients' quality of life. This way of working reflects our commitment to a responsible business model, oriented towards both health outcomes and social impact.

Cardiology / Pulmonology

Ferrer offers therapeutic options aimed at the comprehensive management of pulmonary hypertension, both in Group 1 (PAH) and Group 3 (HP-ILD). They are focused on improving pulmonary vasodilation, functional capacity and symptom control in patients with advanced disease or associated interstitial lung pathology.

 

These solutions provide clinically relevant and adjustable benefits, backed by evidence, contributing to improved patient outcomes and quality of life.

OUR  PRODUCTS

We specialize in own-brand prescription drugs, mainly for hospital use.

Contact Information

Ferrer Peru

Monte Rosa 255 Piso 4 – Chacarilla – Santiago de Surco – Lima 33

+51 1 625 9700